PUBLISHER: KBV Research | PRODUCT CODE: 1155660
PUBLISHER: KBV Research | PRODUCT CODE: 1155660
North America Sustained Release Excipients Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Product (Polymers, Minerals, Sugars, Gelatin & Chitosan), By Technology, By Country and Growth Forecast, 2022 - 2028
The North America Sustained Release Excipients Market would witness market growth of 7.8% CAGR during the forecast period (2022-2028).
Excipients serve as polymeric screens for drug powders as well as multi-particulate systems in oral solid dose (OSD) forms as well as matrix formers in matrix delivery systems. Excipients in liquid oral products can help conceal tastes and shield the gastrointestinal membrane. Excipients can help prevent alcohol-induced dosage dumping and provide a misuse deterrent in some circumstances.
There are a number of factors taken into account when choosing particular excipients for sustained release formulations. To ensure that the required dissolution profiles can be obtained with a specific excipient, and that a satisfactory in vivo-in vitro correlation is attainable, dosage form kind and design are taken into account in addition to the solubility of API.
Concerns about patient cooperation and safety are also taken into account. Ethylcellulose continues to be the preferred polymer in multi-particulate medication delivery systems either with or without an extra coating platform. The choice of the polymer depends on the properties and kind of dosage form of the medicine.
In this region, chronic diseases are on the rise overall, according to trends. Heart disease, respiratory disorders, cancer, stroke, injuries, diabetes, Alzheimer's disease, pneumonia and influenza, renal disease, and septicemia are currently the top ten health issues in America. These issues get worse due to the aging population of the country, existing risk factors (poor nutrition, tobacco use, and lack of physical activity), and medical advancements that lengthen lifespan (if not also improve general health). The Centers for Disease Control estimate that chronic diseases alone in the United States account for around three-fourths of total healthcare costs annually.
The US market dominated the North America Sustained Release Excipients Market by Country in 2021; thereby, achieving a market value of $404.2 million by 2028. The Canada market is experiencing a CAGR of 10.2% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 9.3% during (2022 - 2028).
Based on Route of Administration, the market is segmented into Oral, Transdermal, Vaginal, Intravenous, Ophthalmic, Subcutaneous, Intramuscular, and Others. Based on Product, the market is segmented into Polymers, Minerals, Sugars, Gelatin & Chitosan, and Others. Based on Technology, the market is segmented into Targeted Delivery, Implants, Wurster Technique, Transdermal, Micro Encapsulation, and Coacervation & Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BASF SE, International Flavors & Fragrances, Inc., Ashland Global Holdings Inc., Evonik Industries AG, Croda International Plc, Gattefosse, Merck Group, Pfizer, Inc., Novartis AG and AstraZeneca Plc.
Scope of the Study
Market Segments covered in the Report:
By Route of Administration
- Oral
- Transdermal
- Vaginal
- Intravenous
- Ophthalmic
- Subcutaneous
- Intramuscular
- Others
By Product
- Polymers
- Minerals
- Sugars
- Gelatin & Chitosan
- Others
By Technology
- Targeted Delivery
- Implants
- Wurster Technique
- Transdermal
- Micro Encapsulation
- Coacervation & Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- BASF SE
- International Flavors & Fragrances, Inc.
- Ashland Global Holdings Inc.
- Evonik Industries AG
- Croda International Plc
- Gattefosse
- Merck Group
- Pfizer, Inc.
- Novartis AG
- AstraZeneca Plc
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Sustained Release Excipients Market, by Route of Administration
- 1.4.2 North America Sustained Release Excipients Market, by Product
- 1.4.3 North America Sustained Release Excipients Market, by Technology
- 1.4.4 North America Sustained Release Excipients Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Strategies deployed in Sustained Release Excipients Market
Chapter 4. North America Sustained Release Excipients Market by Route of Administration
- 4.1 North America Oral Market by Country
- 4.2 North America Transdermal Market by Country
- 4.3 North America Vaginal Market by Country
- 4.4 North America Intravenous Market by Country
- 4.5 North America Ophthalmic Market by Country
- 4.6 North America Subcutaneous Market by Country
- 4.7 North America Intramuscular Market by Country
- 4.8 North America Others Market by Country
Chapter 5. North America Sustained Release Excipients Market by Product
- 5.1 North America Polymers Market by Country
- 5.2 North America Minerals Market by Country
- 5.3 North America Sugars Market by Country
- 5.4 North America Gelatin & Chitosan Market by Country
- 5.5 North America Others Market by Country
Chapter 6. North America Sustained Release Excipients Market by Technology
- 6.1 North America Targeted Delivery Market by Country
- 6.2 North America Implants Market by Country
- 6.3 North America Wurster Technique Market by Country
- 6.4 North America Transdermal Market by Country
- 6.5 North America Micro Encapsulation Market by Country
- 6.6 North America Coacervation & Others Market by Country
Chapter 7. North America Sustained Release Excipients Market by Country
- 7.1 US Sustained Release Excipients Market
- 7.1.1 US Sustained Release Excipients Market by Route of Administration
- 7.1.2 US Sustained Release Excipients Market by Product
- 7.1.3 US Sustained Release Excipients Market by Technology
- 7.2 Canada Sustained Release Excipients Market
- 7.2.1 Canada Sustained Release Excipients Market by Route of Administration
- 7.2.2 Canada Sustained Release Excipients Market by Product
- 7.2.3 Canada Sustained Release Excipients Market by Technology
- 7.3 Mexico Sustained Release Excipients Market
- 7.3.1 Mexico Sustained Release Excipients Market by Route of Administration
- 7.3.2 Mexico Sustained Release Excipients Market by Product
- 7.3.3 Mexico Sustained Release Excipients Market by Technology
- 7.4 Rest of North America Sustained Release Excipients Market
- 7.4.1 Rest of North America Sustained Release Excipients Market by Route of Administration
- 7.4.2 Rest of North America Sustained Release Excipients Market by Product
- 7.4.3 Rest of North America Sustained Release Excipients Market by Technology
Chapter 8. Company Profiles
- 8.1 BASF SE
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.2 International Flavors & Fragrances, Inc.
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segment & Regional Analysis
- 8.2.4 Research & Development Expense
- 8.3 Ashland Global Holdings Inc. (Pharmachem Laboratories Inc.)
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expenses
- 8.4 Evonik Industries AG (RAG-Stiftung)
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Segmental and Regional Analysis
- 8.4.4 Research & Development Expenses
- 8.4.5 Recent strategies and developments:
- 8.4.5.1 Partnerships, Collaborations, and Agreements:
- 8.4.5.2 Product Launches and Product Expansions:
- 8.4.5.3 Acquisition and Mergers:
- 8.5 Croda International PLC
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Segmental and Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 Recent strategies and developments:
- 8.5.5.1 Partnerships, Collaborations, and Agreements:
- 8.5.5.2 Product Launches and Product Expansions:
- 8.6 Merck Group
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 Research & Development Expense
- 8.7 Pfizer, Inc.
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Regional & Segmental Analysis
- 8.7.4 Research & Development Expense
- 8.8 Novartis AG
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Segmental and Regional Analysis
- 8.8.4 Research & Development Expense
- 8.9 AstraZeneca PLC
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Regional Analysis
- 8.9.4 Research & Development Expenses
- 8.10. Gattefosse
- 8.10.1 Company Overview
LIST OF TABLES
- TABLE 1 North America Sustained Release Excipients Market, 2018 - 2021, USD Million
- TABLE 2 North America Sustained Release Excipients Market, 2022 - 2028, USD Million
- TABLE 3 North America Sustained Release Excipients Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 4 North America Sustained Release Excipients Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 5 North America Oral Market by Country, 2018 - 2021, USD Million
- TABLE 6 North America Oral Market by Country, 2022 - 2028, USD Million
- TABLE 7 North America Transdermal Market by Country, 2018 - 2021, USD Million
- TABLE 8 North America Transdermal Market by Country, 2022 - 2028, USD Million
- TABLE 9 North America Vaginal Market by Country, 2018 - 2021, USD Million
- TABLE 10 North America Vaginal Market by Country, 2022 - 2028, USD Million
- TABLE 11 North America Intravenous Market by Country, 2018 - 2021, USD Million
- TABLE 12 North America Intravenous Market by Country, 2022 - 2028, USD Million
- TABLE 13 North America Ophthalmic Market by Country, 2018 - 2021, USD Million
- TABLE 14 North America Ophthalmic Market by Country, 2022 - 2028, USD Million
- TABLE 15 North America Subcutaneous Market by Country, 2018 - 2021, USD Million
- TABLE 16 North America Subcutaneous Market by Country, 2022 - 2028, USD Million
- TABLE 17 North America Intramuscular Market by Country, 2018 - 2021, USD Million
- TABLE 18 North America Intramuscular Market by Country, 2022 - 2028, USD Million
- TABLE 19 North America Others Market by Country, 2018 - 2021, USD Million
- TABLE 20 North America Others Market by Country, 2022 - 2028, USD Million
- TABLE 21 North America Sustained Release Excipients Market by Product, 2018 - 2021, USD Million
- TABLE 22 North America Sustained Release Excipients Market by Product, 2022 - 2028, USD Million
- TABLE 23 North America Polymers Market by Country, 2018 - 2021, USD Million
- TABLE 24 North America Polymers Market by Country, 2022 - 2028, USD Million
- TABLE 25 North America Minerals Market by Country, 2018 - 2021, USD Million
- TABLE 26 North America Minerals Market by Country, 2022 - 2028, USD Million
- TABLE 27 North America Sugars Market by Country, 2018 - 2021, USD Million
- TABLE 28 North America Sugars Market by Country, 2022 - 2028, USD Million
- TABLE 29 North America Gelatin & Chitosan Market by Country, 2018 - 2021, USD Million
- TABLE 30 North America Gelatin & Chitosan Market by Country, 2022 - 2028, USD Million
- TABLE 31 North America Others Market by Country, 2018 - 2021, USD Million
- TABLE 32 North America Others Market by Country, 2022 - 2028, USD Million
- TABLE 33 North America Sustained Release Excipients Market by Technology, 2018 - 2021, USD Million
- TABLE 34 North America Sustained Release Excipients Market by Technology, 2022 - 2028, USD Million
- TABLE 35 North America Targeted Delivery Market by Country, 2018 - 2021, USD Million
- TABLE 36 North America Targeted Delivery Market by Country, 2022 - 2028, USD Million
- TABLE 37 North America Implants Market by Country, 2018 - 2021, USD Million
- TABLE 38 North America Implants Market by Country, 2022 - 2028, USD Million
- TABLE 39 North America Wurster Technique Market by Country, 2018 - 2021, USD Million
- TABLE 40 North America Wurster Technique Market by Country, 2022 - 2028, USD Million
- TABLE 41 North America Transdermal Market by Country, 2018 - 2021, USD Million
- TABLE 42 North America Transdermal Market by Country, 2022 - 2028, USD Million
- TABLE 43 North America Micro Encapsulation Market by Country, 2018 - 2021, USD Million
- TABLE 44 North America Micro Encapsulation Market by Country, 2022 - 2028, USD Million
- TABLE 45 North America Coacervation & Others Market by Country, 2018 - 2021, USD Million
- TABLE 46 North America Coacervation & Others Market by Country, 2022 - 2028, USD Million
- TABLE 47 North America Sustained Release Excipients Market by Country, 2018 - 2021, USD Million
- TABLE 48 North America Sustained Release Excipients Market by Country, 2022 - 2028, USD Million
- TABLE 49 US Sustained Release Excipients Market, 2018 - 2021, USD Million
- TABLE 50 US Sustained Release Excipients Market, 2022 - 2028, USD Million
- TABLE 51 US Sustained Release Excipients Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 52 US Sustained Release Excipients Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 53 US Sustained Release Excipients Market by Product, 2018 - 2021, USD Million
- TABLE 54 US Sustained Release Excipients Market by Product, 2022 - 2028, USD Million
- TABLE 55 US Sustained Release Excipients Market by Technology, 2018 - 2021, USD Million
- TABLE 56 US Sustained Release Excipients Market by Technology, 2022 - 2028, USD Million
- TABLE 57 Canada Sustained Release Excipients Market, 2018 - 2021, USD Million
- TABLE 58 Canada Sustained Release Excipients Market, 2022 - 2028, USD Million
- TABLE 59 Canada Sustained Release Excipients Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 60 Canada Sustained Release Excipients Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 61 Canada Sustained Release Excipients Market by Product, 2018 - 2021, USD Million
- TABLE 62 Canada Sustained Release Excipients Market by Product, 2022 - 2028, USD Million
- TABLE 63 Canada Sustained Release Excipients Market by Technology, 2018 - 2021, USD Million
- TABLE 64 Canada Sustained Release Excipients Market by Technology, 2022 - 2028, USD Million
- TABLE 65 Mexico Sustained Release Excipients Market, 2018 - 2021, USD Million
- TABLE 66 Mexico Sustained Release Excipients Market, 2022 - 2028, USD Million
- TABLE 67 Mexico Sustained Release Excipients Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 68 Mexico Sustained Release Excipients Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 69 Mexico Sustained Release Excipients Market by Product, 2018 - 2021, USD Million
- TABLE 70 Mexico Sustained Release Excipients Market by Product, 2022 - 2028, USD Million
- TABLE 71 Mexico Sustained Release Excipients Market by Technology, 2018 - 2021, USD Million
- TABLE 72 Mexico Sustained Release Excipients Market by Technology, 2022 - 2028, USD Million
- TABLE 73 Rest of North America Sustained Release Excipients Market, 2018 - 2021, USD Million
- TABLE 74 Rest of North America Sustained Release Excipients Market, 2022 - 2028, USD Million
- TABLE 75 Rest of North America Sustained Release Excipients Market by Route of Administration, 2018 - 2021, USD Million
- TABLE 76 Rest of North America Sustained Release Excipients Market by Route of Administration, 2022 - 2028, USD Million
- TABLE 77 Rest of North America Sustained Release Excipients Market by Product, 2018 - 2021, USD Million
- TABLE 78 Rest of North America Sustained Release Excipients Market by Product, 2022 - 2028, USD Million
- TABLE 79 Rest of North America Sustained Release Excipients Market by Technology, 2018 - 2021, USD Million
- TABLE 80 Rest of North America Sustained Release Excipients Market by Technology, 2022 - 2028, USD Million
- TABLE 81 Key Information - BASF SE
- TABLE 82 Key information - International Flavors & Fragrances, Inc.
- TABLE 83 Key Information - Ashland Global Holdings Inc.
- TABLE 84 Key Information - Evonik Industries AG
- TABLE 85 Key Information - Croda International PLC
- TABLE 86 key Information - Merck GrouP
- TABLE 87 Key Information - Pfizer, Inc.
- TABLE 88 Key Information - Novartis AG
- TABLE 89 KEY INFORMATION - ASTRAZENECA PLC
- TABLE 90 Key Information - Gattefosse
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Recent strategies and developments: Evonik Industries AG
